Sermonix Pharmaceuticals LLC

Organization

Columbus, OH, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Lasofoxifene treatment of aromatase-resistant ER+cancer
- Patent number 12,023,321
- Issue date Jul 2, 2024
- Sermonix Pharmaceuticals, Inc.
- Barry Samuel Komm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
LASOFOXIFENE TREATMENT OF AROMATASE-RESISTANT ER+ CANCER
- Publication number 20240358677
- Publication date Oct 31, 2024
- Sermonix Pharmaceuticals, Inc.
- Barry Samuel KOMM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LASOFOXIFENE COMBINATION TREATMENT OF ER+ BREAST CANCER THAT HAS PR...
- Publication number 20240122896
- Publication date Apr 18, 2024
- Sermonix Pharmaceuticals, Inc.
- David J. PORTMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LASOFOXIFENE COMBINATION TREATMENT OF ER+ BREAST CANCER THAT HAS PR...
- Publication number 20230381138
- Publication date Nov 30, 2023
- Sermonix Pharmaceuticals, Inc.
- David J. PORTMAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LASOFOXIFENE TREATMENT OF AROMATASE-RESISTANT ER+ CANCER
- Publication number 20230321035
- Publication date Oct 12, 2023
- Sermonix Pharmaceuticals, Inc.
- Barry Samuel KOMM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LASOFOXIFENE TREATMENT OF AROMATASE-RESISTANT ER+ CANCER
- Publication number 20230149350
- Publication date May 18, 2023
- Sermonix Pharmaceuticals, Inc.
- Barry Samuel KOMM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LASOFOXIFENE TREATMENT OF VVA AND OSTEOPOROSIS IN SURVIVORS OF BREA...
- Publication number 20220133691
- Publication date May 5, 2022
- Sermonix Pharmaceuticals, Inc.
- David J. PORTMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LASOFOXIFENE TREATMENT OF VVA AND OSTEOPOROSIS IN SURVIVORS OF BREA...
- Publication number 20190231743
- Publication date Aug 1, 2019
- Sermonix Pharmaceuticals, LLC
- David J. PORTMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
99089165 - ESROLAS
- Serial number 99089165
- Filing date Mar 18, 2025
- Sermonix Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97141480
- Serial number 97141480
- Registration number 7732429
- Filing date Nov 24, 2021
- Sermonix Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90583044 - ESROLAS
- Serial number 90583044
- Filing date Mar 16, 2021
- Sermonix Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88681480 - SERMONIX PHARMACEUTICALS
- Serial number 88681480
- Registration number 7287506
- Filing date Nov 5, 2019
- Sermonix Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88681484 - SERMONIX
- Serial number 88681484
- Registration number 7287507
- Filing date Nov 5, 2019
- Sermonix Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
87007615 - SERMONIX PHARMACEUTICALS
- Serial number 87007615
- Filing date Apr 20, 2016
- Sermonix Pharmaceuticals LLC
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86923288 - SERMONIX
- Serial number 86923288
- Filing date Feb 29, 2016
- Sermonix Pharmaceuticals LLC
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86764238 - FABLYN
- Serial number 86764238
- Filing date Sep 22, 2015
- Sermonix Pharmaceuticals LLC
- 5 - Pharmaceutical and veterinary preparations

Sermonix Pharmaceuticals LLC

Organization

Patents Grantslast 30 patents

Lasofoxifene treatment of aromatase-resistant ER+cancer

Patents Applicationslast 30 patents

LASOFOXIFENE TREATMENT OF AROMATASE-RESISTANT ER+ CANCER

LASOFOXIFENE COMBINATION TREATMENT OF ER+ BREAST CANCER THAT HAS PR...

LASOFOXIFENE COMBINATION TREATMENT OF ER+ BREAST CANCER THAT HAS PR...

LASOFOXIFENE TREATMENT OF AROMATASE-RESISTANT ER+ CANCER

LASOFOXIFENE TREATMENT OF AROMATASE-RESISTANT ER+ CANCER

LASOFOXIFENE TREATMENT OF VVA AND OSTEOPOROSIS IN SURVIVORS OF BREA...

LASOFOXIFENE TREATMENT OF VVA AND OSTEOPOROSIS IN SURVIVORS OF BREA...

Trademarklast 30 trademarks

99089165 - ESROLAS

97141480

90583044 - ESROLAS

88681480 - SERMONIX PHARMACEUTICALS

88681484 - SERMONIX

87007615 - SERMONIX PHARMACEUTICALS

86923288 - SERMONIX

86764238 - FABLYN